Paul Tudor Jones's BLTE Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 1,596 shares of Belite Bio, Inc (BLTE) worth $254,466, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Paul Tudor Jones has initiated a new position in BLTE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Belite Bio (BLTE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Belite Bio (BLTE) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +1,596 | New Buy | 1,596 | $159.44 |
Paul Tudor Jones's Belite Bio Investment FAQs
Paul Tudor Jones first purchased Belite Bio, Inc (BLTE) in Q1 2026, acquiring 1,596 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Belite Bio, Inc (BLTE) for 1 quarters since Q1 2026.
Paul Tudor Jones's largest addition to Belite Bio, Inc (BLTE) was in Q1 2026, adding 1,596 shares worth $254,466.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 1,596 shares of Belite Bio, Inc (BLTE), valued at approximately $254,466.
As of the Q1 2026 filing, Belite Bio, Inc (BLTE) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Belite Bio, Inc (BLTE) was 1,596 shares, as reported at the end of Q1 2026.